Patents by Inventor Peter L. A. Giesen

Peter L. A. Giesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8343730
    Abstract: A method is provided for determining in real time the course of proteolytic, e.g., thrombin activity, in a sample of clotting blood or plasma. By frequent mixing of a sample, clot formation may be controlled in a dense manner such that the majority of the sample remains fluid. This will inhibit cell precipitation and allow for informative monitoring as signal substrate is added.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: January 1, 2013
    Assignee: Thrombinoscope B.V.
    Inventors: Peter L. A. Giesen, Kerry Tappenden, Wynne Jones
  • Publication number: 20120135436
    Abstract: A reliable, fast and convenient method is provided to determine the change in concentration of enzyme in time in a biological medium in the presence of a signal substrate that corrects for substrate consumption, color-dependency of the signal and non-linearity between the concentration of the leaving group of the signal substrate and the amount of signal. The method comprises the measurement of a calibrator curve in a suitable medium, such as a buffer, to determine the characteristics of the measured curve. These characteristics will then allow to obtain this whole curve or a sufficient part thereof again through a mathematical procedure based on a single-point measurement in a sample of a medium in which the enzyme generation takes place. This has the great advantage that there is no need to measure the whole calibrator curve in each individual medium, since a single-point measurement is adequate.
    Type: Application
    Filed: February 3, 2012
    Publication date: May 31, 2012
    Inventors: Peter L.A. Giesen, Timothy C.P. Van Asten
  • Patent number: 8133696
    Abstract: Methods and kits to determine thrombin activity are provided. They have the great advantage that there is no need to measure the whole calibrator curve in each individual medium, since a single-point measurement is adequate.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: March 13, 2012
    Assignee: Thrombinoscope B.V.
    Inventors: Peter L. A. Giesen, Timothy C. P. Van Asten
  • Publication number: 20110020850
    Abstract: A reliable, fast and convenient method is provided to determine the change in concentration of enzyme in time in a biological medium in the presence of a signal substrate that corrects for substrate consumption, color-dependency of the signal and non-linearity between the concentration of the leaving group of the signal substrate and the amount of signal. The method comprises the measurement of a calibrator curve in a suitable medium, such as a buffer, to determine the characteristics of the measured curve. These characteristics will then allow to obtain this whole curve or a sufficient part thereof again through a mathematical procedure based on a single-point measurement in a sample of a medium in which the enzyme generation takes place. This has the great advantage that there is no need to measure the whole calibrator curve in each individual medium, since a single-point measurement is adequate.
    Type: Application
    Filed: June 6, 2007
    Publication date: January 27, 2011
    Inventors: Peter L.A. Giesen, Timothy C.P. Van Asten
  • Publication number: 20100105091
    Abstract: A method is provided for determining in real time the course of thrombin activity in a sample of clotting blood or plasma as it appears in and disappears from the sample which comprises adding a signal substrate to said sample, said signal substrate causing a detectable signal related to the amount of conversion product formed upon reaction by the generated proteolytic activity, monitoring the signal development in time in said sample to provide a curve, and mixing said sample frequently so that clot formation occurs in a dense manner such that the majority of the sample remains fluid and that cell precipitation is inhibited, wherein said monitoring and mixing steps are repeated and performed in an alternate way.
    Type: Application
    Filed: November 2, 2007
    Publication date: April 29, 2010
    Applicant: THROMBINOSCOPE B.V.
    Inventors: Peter L.A. Giesen, Kerry Tappenden, Wynne Jones